177 related articles for article (PubMed ID: 16434211)
1. Establishment of a yeast system that stably expresses human cytochrome P450 reductase: application for the study of drug metabolism of cytochrome P450s in vitro.
Cheng J; Wan DF; Gu JR; Gong Y; Yang SL; Hao DC; Yang L
Protein Expr Purif; 2006 Jun; 47(2):467-76. PubMed ID: 16434211
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a novel host, high-red yeast that stably expresses hamster NADPH-cytochrome P450 oxidoreductase: usefulness for examination of the function of mammalian cytochrome P450.
Ohgiya S; Goda T; Hoshino T; Kamataki T; Ishizaki K
Arch Biochem Biophys; 1997 Jul; 343(2):215-24. PubMed ID: 9224733
[TBL] [Abstract][Full Text] [Related]
3. Optimization of yeast-expressed human liver cytochrome P450 3A4 catalytic activities by coexpressing NADPH-cytochrome P450 reductase and cytochrome b5.
Peyronneau MA; Renaud JP; Truan G; Urban P; Pompon D; Mansuy D
Eur J Biochem; 1992 Jul; 207(1):109-16. PubMed ID: 1628642
[TBL] [Abstract][Full Text] [Related]
4. Coexpression of genetically engineered fused enzyme between yeast NADPH-P450 reductase and human cytochrome P450 3A4 and human cytochrome b5 in yeast.
Hayashi K; Sakaki T; Kominami S; Inouye K; Yabusaki Y
Arch Biochem Biophys; 2000 Sep; 381(1):164-70. PubMed ID: 11019832
[TBL] [Abstract][Full Text] [Related]
5. In vivo reconstitution of highly active Candida maltosa cytochrome P450 monooxygenase systems in inducible membranes of Saccharomyces cerevisiae.
Zimmer T; Kaminski K; Scheller U; Vogel F; Schunck WH
DNA Cell Biol; 1995 Jul; 14(7):619-28. PubMed ID: 7626221
[TBL] [Abstract][Full Text] [Related]
6. Functional expression of fused enzymes between human cytochrome P4501A1 and human NADPH-cytochrome P450 oxidoreductase in Saccharomyces cerevisiae.
Wittekindt NE; Würgler FE; Sengstag C
DNA Cell Biol; 1995 Apr; 14(4):273-83. PubMed ID: 7710684
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of specifically active recombinant fused enzymes consisting of CYP3A4, NADPH-cytochrome P450 oxidoreductase, and cytochrome b5.
Inui H; Maeda A; Ohkawa H
Biochemistry; 2007 Sep; 46(35):10213-21. PubMed ID: 17691855
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of approach to predict the contribution of multiple cytochrome P450s in drug metabolism using relative activity factor: effects of the differences in expression levels of NADPH-cytochrome P450 reductase and cytochrome b(5) in the expression system and the differences in the marker activities.
Nakajima M; Tane K; Nakamura S; Shimada N; Yamazaki H; Yokoi T
J Pharm Sci; 2002 Apr; 91(4):952-63. PubMed ID: 11948533
[TBL] [Abstract][Full Text] [Related]
9. Competition between cytochrome P-450 isozymes for NADPH-cytochrome P-450 oxidoreductase affects drug metabolism.
Li DN; Pritchard MP; Hanlon SP; Burchell B; Wolf CR; Friedberg T
J Pharmacol Exp Ther; 1999 May; 289(2):661-7. PubMed ID: 10215637
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of isoflavone synthase activity by co-expression of P450 reductase from rice.
Kim DH; Kim BG; Lee HJ; Lim Y; Hur HG; Ahn JH
Biotechnol Lett; 2005 Sep; 27(17):1291-4. PubMed ID: 16215827
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of electron transfer between NADPH-cytochrome P450 reductase and cytochrome P450 3A4.
Farooq Y; Roberts GC
Biochem J; 2010 Dec; 432(3):485-93. PubMed ID: 20879989
[TBL] [Abstract][Full Text] [Related]
12. Improved cloning and expression of cytochrome P450s and cytochrome P450 reductase in yeast.
Hamann T; Møller BL
Protein Expr Purif; 2007 Nov; 56(1):121-7. PubMed ID: 17826178
[TBL] [Abstract][Full Text] [Related]
13. In vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase. Comparison to human liver microsomes and precision-cut liver tissue slices.
Rodrigues AD; Mulford DJ; Lee RD; Surber BW; Kukulka MJ; Ferrero JL; Thomas SB; Shet MS; Estabrook RW
Drug Metab Dispos; 1995 Jul; 23(7):765-75. PubMed ID: 7587966
[TBL] [Abstract][Full Text] [Related]
14. Expression of human liver cytochrome P450 IIIA4 in yeast. A functional model for the hepatic enzyme.
Renaud JP; Cullin C; Pompon D; Beaune P; Mansuy D
Eur J Biochem; 1990 Dec; 194(3):889-96. PubMed ID: 2269307
[TBL] [Abstract][Full Text] [Related]
15. A genetically engineered P450 monooxygenase: construction of the functional fused enzyme between rat cytochrome P450c and NADPH-cytochrome P450 reductase.
Murakami H; Yabusaki Y; Sakaki T; Shibata M; Ohkawa H
DNA; 1987 Jun; 6(3):189-97. PubMed ID: 3109864
[TBL] [Abstract][Full Text] [Related]
16. Recombinant yeast in drug metabolism.
Renaud JP; Peyronneau MA; Urban P; Truan G; Cullin C; Pompon D; Beaune P; Mansuy D
Toxicology; 1993 Oct; 82(1-3):39-52. PubMed ID: 8236280
[TBL] [Abstract][Full Text] [Related]
17. Coexpression of a human P450 (CYP3A4) and P450 reductase generates a highly functional monooxygenase system in Escherichia coli.
Blake JA; Pritchard M; Ding S; Smith GC; Burchell B; Wolf CR; Friedberg T
FEBS Lett; 1996 Nov; 397(2-3):210-4. PubMed ID: 8955349
[TBL] [Abstract][Full Text] [Related]
18. Expression of cloned yeast NADPH-cytochrome P450 reductase gene in Saccharomyces cerevisiae.
Murakami H; Yabusaki Y; Sakaki T; Shibata M; Ohkawa H
J Biochem; 1990 Nov; 108(5):859-65. PubMed ID: 2127933
[TBL] [Abstract][Full Text] [Related]
19. Preparative synthesis of drug metabolites using human cytochrome P450s 3A4, 2C9 and 1A2 with NADPH-P450 reductase expressed in Escherichia coli.
Vail RB; Homann MJ; Hanna I; Zaks A
J Ind Microbiol Biotechnol; 2005 Feb; 32(2):67-74. PubMed ID: 15739102
[TBL] [Abstract][Full Text] [Related]
20. Steroid biotransformations in biphasic systems with Yarrowia lipolytica expressing human liver cytochrome P450 genes.
Braun A; Geier M; Bühler B; Schmid A; Mauersberger S; Glieder A
Microb Cell Fact; 2012 Aug; 11():106. PubMed ID: 22876969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
